APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cutting Biopsy System For Breast Lesion

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cutting Biopsy System For Breast Lesion Market Outlook and Growth Opportunities 2026

26 December 2025199 pages

Choose your research edition.

Industry ResearchCutting Biopsy System For Breast Lesion Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Cutting Biopsy System For Breast Lesion Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Cutting Biopsy System For Breast Lesion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cutting Biopsy System For Breast Lesion Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cutting Biopsy System For Breast Lesion Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cutting Biopsy System For Breast Lesion market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cutting Biopsy System For Breast Lesion market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cutting Biopsy System For Breast Lesion market include BD, Danaher Corporation, Cultiva Medical, Chongqing Xishan Science & Technology and GMT Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cutting Biopsy System For Breast Lesion market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cutting Biopsy System For Breast Lesion and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cutting Biopsy System For Breast Lesion revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cutting Biopsy System For Breast Lesion market.

Cutting Biopsy System For Breast Lesion Segment by Company

BD

Danaher Corporation

Cultiva Medical

Chongqing Xishan Science & Technology

GMT Medical

Cutting Biopsy System For Breast Lesion Segment by Type

Half Cut

Full Cut

Cutting Biopsy System For Breast Lesion Segment by Application

Malignant Breast Tumors

Benign Breast Tumors

Cutting Biopsy System For Breast Lesion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cutting Biopsy System For Breast Lesion status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cutting Biopsy System For Breast Lesion key companies, revenue, market share, and recent developments.

3. To split the Cutting Biopsy System For Breast Lesion breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cutting Biopsy System For Breast Lesion market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cutting Biopsy System For Breast Lesion significant trends, drivers, influence factors in global and regions.

6. To analyze Cutting Biopsy System For Breast Lesion competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cutting Biopsy System For Breast Lesion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cutting Biopsy System For Breast Lesion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cutting Biopsy System For Breast Lesion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cutting Biopsy System For Breast Lesion industry.

Chapter 3: Detailed analysis of Cutting Biopsy System For Breast Lesion company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cutting Biopsy System For Breast Lesion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cutting Biopsy System For Breast Lesion in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cutting Biopsy System For Breast Lesion Industry Trends Table 2. Cutting Biopsy System For Breast Lesion Industry Drivers Table 3. Cutting Biopsy System For Breast Lesion Industry Opportunities and Challenges Table 4. Cutting Biopsy System For Breast Lesion Industry Restraints Table 5. Global Cutting Biopsy System For Breast Lesion Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cutting Biopsy System For Breast Lesion Revenue Share by Company (2021-2026) Table 7. Global Cutting Biopsy System For Breast Lesion Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cutting Biopsy System For Breast Lesion Key Company Manufacturing Base & Headquarters Table 9. Global Cutting Biopsy System For Breast Lesion Company, Product Type & Application Table 10. Global Cutting Biopsy System For Breast Lesion Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cutting Biopsy System For Breast Lesion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Half Cut Table 15. Significant Companies of Full Cut Table 16. Global Cutting Biopsy System For Breast Lesion Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cutting Biopsy System For Breast Lesion Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cutting Biopsy System For Breast Lesion Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Type (2021-2026) Table 20. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Malignant Breast Tumors Table 22. Significant Companies of Benign Breast Tumors Table 23. Global Cutting Biopsy System For Breast Lesion Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Cutting Biopsy System For Breast Lesion Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Cutting Biopsy System For Breast Lesion Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Application (2021-2026) Table 27. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Application (2027-2032) Table 28. Global Cutting Biopsy System For Breast Lesion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cutting Biopsy System For Breast Lesion Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Region (2021-2026) Table 31. Global Cutting Biopsy System For Breast Lesion Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Region (2027-2032) Table 33. Global Cutting Biopsy System For Breast Lesion Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cutting Biopsy System For Breast Lesion Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Cutting Biopsy System For Breast Lesion Sales Value Market Share by Country (2021-2026) Table 36. Global Cutting Biopsy System For Breast Lesion Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Cutting Biopsy System For Breast Lesion Sales Value Market Share by Country (2027-2032) Table 38. BD Company Information Table 39. BD Business Overview Table 40. BD Cutting Biopsy System For Breast Lesion Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. BD Cutting Biopsy System For Breast Lesion Product Portfolio Table 42. BD Recent Development Table 43. Danaher Corporation Company Information Table 44. Danaher Corporation Business Overview Table 45. Danaher Corporation Cutting Biopsy System For Breast Lesion Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Danaher Corporation Cutting Biopsy System For Breast Lesion Product Portfolio Table 47. Danaher Corporation Recent Development Table 48. Cultiva Medical Company Information Table 49. Cultiva Medical Business Overview Table 50. Cultiva Medical Cutting Biopsy System For Breast Lesion Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Cultiva Medical Cutting Biopsy System For Breast Lesion Product Portfolio Table 52. Cultiva Medical Recent Development Table 53. Chongqing Xishan Science & Technology Company Information Table 54. Chongqing Xishan Science & Technology Business Overview Table 55. Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Product Portfolio Table 57. Chongqing Xishan Science & Technology Recent Development Table 58. GMT Medical Company Information Table 59. GMT Medical Business Overview Table 60. GMT Medical Cutting Biopsy System For Breast Lesion Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. GMT Medical Cutting Biopsy System For Breast Lesion Product Portfolio Table 62. GMT Medical Recent Development Table 63. Research Programs/Design for This Report Table 64. Authors List of This Report Table 65. Secondary Sources Table 66. Primary Sources List of Figures Figure 1. Cutting Biopsy System For Breast Lesion Product Image Figure 2. Global Cutting Biopsy System For Breast Lesion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cutting Biopsy System For Breast Lesion Market Size (2021-2032) & (US$ Million) Figure 4. Global Cutting Biopsy System For Breast Lesion Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Half Cut Image Figure 8. Full Cut Image Figure 9. Global Cutting Biopsy System For Breast Lesion Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cutting Biopsy System For Breast Lesion Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Type (2021-2032) Figure 12. Malignant Breast Tumors Image Figure 13. Benign Breast Tumors Image Figure 14. Global Cutting Biopsy System For Breast Lesion Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cutting Biopsy System For Breast Lesion Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Application (2021-2032) Figure 17. Global Cutting Biopsy System For Breast Lesion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Cutting Biopsy System For Breast Lesion Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Cutting Biopsy System For Breast Lesion Sales Value (2021-2032) & (US$ Million) Figure 20. North America Cutting Biopsy System For Breast Lesion Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Cutting Biopsy System For Breast Lesion Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Cutting Biopsy System For Breast Lesion Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Cutting Biopsy System For Breast Lesion Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Cutting Biopsy System For Breast Lesion Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Cutting Biopsy System For Breast Lesion Sales Value (2021-2032) & (US$ Million) Figure 26. South America Cutting Biopsy System For Breast Lesion Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Cutting Biopsy System For Breast Lesion Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Cutting Biopsy System For Breast Lesion Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Half Cut
  • Full Cut
Applications
  • Malignant Breast Tumors
  • Benign Breast Tumors
Companies covered
  • BD
  • Danaher Corporation
  • Cultiva Medical
  • Chongqing Xishan Science & Technology
  • GMT Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cutting Biopsy System For Breast Lesion Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cutting Biopsy System For Breast Lesion Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cutting Biopsy System For Breast Lesion Market Dynamics
  1. 2.1 Cutting Biopsy System For Breast Lesion Industry Trends
  2. 2.2 Cutting Biopsy System For Breast Lesion Industry Drivers
  3. 2.3 Cutting Biopsy System For Breast Lesion Industry Opportunities and Challenges
  4. 2.4 Cutting Biopsy System For Breast Lesion Industry Restraints
3 Cutting Biopsy System For Breast Lesion Market by Company
  1. 3.1 Global Cutting Biopsy System For Breast Lesion Company Revenue Ranking in 2025
  2. 3.2 Global Cutting Biopsy System For Breast Lesion Revenue by Company (2021-2026)
  3. 3.3 Global Cutting Biopsy System For Breast Lesion Company Ranking (2024-2026)
  4. 3.4 Global Cutting Biopsy System For Breast Lesion Company Manufacturing Base and Headquarters
  5. 3.5 Global Cutting Biopsy System For Breast Lesion Company Product Type and Application
  6. 3.6 Global Cutting Biopsy System For Breast Lesion Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cutting Biopsy System For Breast Lesion Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cutting Biopsy System For Breast Lesion Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cutting Biopsy System For Breast Lesion Market by Type
  1. 4.1 Cutting Biopsy System For Breast Lesion Type Introduction
  2. 4.1.1 Half Cut
  3. 4.1.2 Full Cut
  4. 4.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Type
  5. 4.2.1 Global Cutting Biopsy System For Breast Lesion Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cutting Biopsy System For Breast Lesion Sales Value Share by Type (2021-2032)
5 Cutting Biopsy System For Breast Lesion Market by Application
  1. 5.1 Cutting Biopsy System For Breast Lesion Application Introduction
  2. 5.1.1 Malignant Breast Tumors
  3. 5.1.2 Benign Breast Tumors
  4. 5.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Application
  5. 5.2.1 Global Cutting Biopsy System For Breast Lesion Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cutting Biopsy System For Breast Lesion Sales Value Share by Application (2021-2032)
6 Cutting Biopsy System For Breast Lesion Regional Value Analysis
  1. 6.1 Global Cutting Biopsy System For Breast Lesion Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cutting Biopsy System For Breast Lesion Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cutting Biopsy System For Breast Lesion Sales Value (2021-2032)
  7. 6.3.2 North America Cutting Biopsy System For Breast Lesion Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cutting Biopsy System For Breast Lesion Sales Value (2021-2032)
  10. 6.4.2 Europe Cutting Biopsy System For Breast Lesion Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cutting Biopsy System For Breast Lesion Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cutting Biopsy System For Breast Lesion Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cutting Biopsy System For Breast Lesion Sales Value (2021-2032)
  16. 6.6.2 South America Cutting Biopsy System For Breast Lesion Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cutting Biopsy System For Breast Lesion Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cutting Biopsy System For Breast Lesion Sales Value Share by Country, 2025 VS 2032
7 Cutting Biopsy System For Breast Lesion Country-level Value Analysis
  1. 7.1 Global Cutting Biopsy System For Breast Lesion Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cutting Biopsy System For Breast Lesion Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cutting Biopsy System For Breast Lesion Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cutting Biopsy System For Breast Lesion Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cutting Biopsy System For Breast Lesion Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cutting Biopsy System For Breast Lesion Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Cutting Biopsy System For Breast Lesion Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 Danaher Corporation
  8. 8.2.1 Danaher Corporation Company Information
  9. 8.2.2 Danaher Corporation Business Overview
  10. 8.2.3 Danaher Corporation Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Danaher Corporation Cutting Biopsy System For Breast Lesion Product Portfolio
  12. 8.2.5 Danaher Corporation Recent Developments
  13. 8.3 Cultiva Medical
  14. 8.3.1 Cultiva Medical Company Information
  15. 8.3.2 Cultiva Medical Business Overview
  16. 8.3.3 Cultiva Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cultiva Medical Cutting Biopsy System For Breast Lesion Product Portfolio
  18. 8.3.5 Cultiva Medical Recent Developments
  19. 8.4 Chongqing Xishan Science & Technology
  20. 8.4.1 Chongqing Xishan Science & Technology Company Information
  21. 8.4.2 Chongqing Xishan Science & Technology Business Overview
  22. 8.4.3 Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Product Portfolio
  24. 8.4.5 Chongqing Xishan Science & Technology Recent Developments
  25. 8.5 GMT Medical
  26. 8.5.1 GMT Medical Company Information
  27. 8.5.2 GMT Medical Business Overview
  28. 8.5.3 GMT Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GMT Medical Cutting Biopsy System For Breast Lesion Product Portfolio
  30. 8.5.5 GMT Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst